Impact of SS18l1 Polymorphism in Predicting Prognosis of Hepatocellular Carcinoma

HPB - United Kingdom
doi 10.1016/j.hpb.2018.06.296
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Role of the E3 Ubiquitin Ligase TRIM4 in Predicting the Prognosis of Hepatocellular Carcinoma

Journal of Cancer
Oncology
2020English

TERT-CLPTM1 Locus Polymorphism (Rs401681) Is Associated With the Prognosis of Hepatocellular Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Systemic Hepatic-Damage Index for Predicting the Prognosis of Hepatocellular Carcinoma After Curative Resection

Frontiers in Physiology
Physiology
2017English

Impact of Spontaneous Tumor Rupture on Prognosis of Patients With T4 Hepatocellular Carcinoma

Journal of Surgical Oncology
MedicineSurgeryOncology
2016English

Predicting Survival in Early Hepatocellular Carcinoma

Gut
Gastroenterology
2005English

Ferroportin in the Progression and Prognosis of Hepatocellular Carcinoma

European Journal of Medical Research
Medicine
2013English

Mitofusin-2 Acts as Biomarker for Predicting Poor Prognosis in Hepatitis B Virus Related Hepatocellular Carcinoma

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2018English

Downregulation of GNA14 in Hepatocellular Carcinoma Indicates an Unfavorable Prognosis

Oncology Letters
Cancer ResearchOncology
2020English

Neutrophils: Driving Progression and Poor Prognosis in Hepatocellular Carcinoma?

British Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy